Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

UMMS Develops New Technology to Study Stem Cells

Published: Wednesday, January 01, 2014
Last Updated: Wednesday, January 01, 2014
Bookmark and Share
Novel method holds potential for guiding stem cell differentiation.

Scientists at UMass Medical School have developed a new technology for manipulating gene expression in human pluripotent stem cells (hPSC). Published in the journal Development, the breakthrough will allow researchers to dissect the underlying mechanisms of human stem cell differentiation and may lead to new avenues for directing development of cell types.

“The ability to control stem cell differentiation holds enormous potential for researchers studying patient-specific disease models and could advance development of new therapeutics for autoimmune diseases such as type 1 diabetes,” said Rene Maehr, PhD, assistant professor of molecular medicine and lead author of the study.

Using a natural defense system found in bacteria called clustered regularly interspaced short palindromic repeats, or CRISPR for short, researchers have shown it’s possible to adapt this programmable system to deliver transcription effectors that positively or negatively regulate gene expression to specific target genes in human pluripotent stem cells without altering the underlying genome.

CRISPR is a kind of adaptive immune system found in archaea and bacteria. It provides resistance to potential invaders, such as plasmids and phages, by recognizing and cleaving foreign genetic elements in a manner similar to how RNAi works in humans and other animals to turn off gene expression. In 2012, it was shown that CRISPR components programmed by RNA guides can deliver effector domains to specific human genes in order to activate or deactivate them.

Dr. Maehr and collaborator Scot Wolfe, PhD, associate professor of biochemistry & molecular pharmacology, have developed an RNA-guided transcription effector system using CRISPR to target developmentally relevant genes and thereby alter the differentiation status of hPSCs. This breakthrough provides researchers a new, rapid method for identifying gene networks that govern the development of stem cells into specific, mature cell types.

Ultimately, Maehr and colleagues believe this system can be used to turn hPSCs into clinically relevant cell types such as pancreatic beta cells and thymic epithelial cells, an ability that until now was out of reach.

“This system now provides a much needed platform for investigating the underlying regulators governing cell differentiation decisions, which can then be used to guide development of patient-specific stem cells into clinically relevant cell types,” said Maehr, who studies type 1 diabetes and autoimmune disorders,. “In the long run, this could open the door to personalized disease models and human stem cell-based therapies.”

“Coupling targeted gene regulatory tools with pluripotent stem cell technology, as demonstrated in our study, will open new avenues for the development of cell-based therapeutics to directly address the unmet needs of a number of patient populations with complex diseases,” said Dr. Wolfe. “We are encouraged by the potential for the CRISPR-based gene regulatory system to allow for the precise manipulation of gene expression in stem cell populations, which should facilitate the discovery of key regulators of cell differentiation needed to generate cell populations that are absent or defective in specific diseases.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!